Found: 117
Select item for more details and to access through your institution.
HbA1c and clinical outcomes after endovascular treatment in patients with posterior circulation large vessel occlusion: a subgroup analysis of a nationwide registry (BASILAR).
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420981354
- By:
- Publication type:
- Article
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420907803
- By:
- Publication type:
- Article
Effective and safe diet therapies for Lennox-Gastaut syndrome with mitochondrial dysfunction.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. N.PAG, doi. 10.1177/1756286419897813
- By:
- Publication type:
- Article
A novel CCM3 mutation associated with cerebral cavernous malformation in a Chinese family.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. N.PAG, doi. 10.1177/1756286420902664
- By:
- Publication type:
- Article
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420969016
- By:
- Publication type:
- Article
Personalized risk prediction of symptomatic intracerebral hemorrhage after stroke thrombolysis using a machine-learning model.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420902358
- By:
- Publication type:
- Article
Cystic echinococcosis causing thrombosis of the inferior vena cava in a patient with multiple sclerosis treated with alemtuzumab.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420954081
- By:
- Publication type:
- Article
Early prediction of the 3-month outcome for individual acute ischemic stroke patients who received intravenous thrombolysis using the N2H3 nomogram model.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420953054
- By:
- Publication type:
- Article
An update on magnetic resonance imaging markers in AD.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420947986
- By:
- Publication type:
- Article
Circulating metabolomics profiling reveals novel pathways associated with cognitive decline in patients with hypertension.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420947973
- By:
- Publication type:
- Article
Post-infectious neurological disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420952901
- By:
- Publication type:
- Article
Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG).
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420949808
- By:
- Publication type:
- Article
Vision improvement in severe acute isolated optic neuritis after plasma exchange treatment in Chinese population: a prospective case series study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420947977
- By:
- Publication type:
- Article
C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420935697
- By:
- Publication type:
- Article
Cerebral venous thrombosis in women of childbearing age: diagnosis, treatment, and prophylaxis during a future pregnancy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420945169
- By:
- Publication type:
- Article
Differential functional connectivity in thalamic and dopaminergic pathways in restless legs syndrome: a meta-analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420941670
- By:
- Publication type:
- Article
Recent developments in MOG-IgG associated neurological disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420945135
- By:
- Publication type:
- Article
Multiple sclerosis and nutrition: back to the future?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Wernicke–Korsakoff syndrome associated with mtDNA disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420938972
- By:
- Publication type:
- Article
Corrigendum to outcome and periprocedural time management in referred versus directly admitted stroke patients treated with thrombectomy.
- Published in:
- 2020
- Publication type:
- Correction Notice
Sex effects across the lifespan in women with multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420936166
- By:
- Publication type:
- Article
Eculizumab as a promising treatment in thymoma-associated myasthenia gravis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420932035
- By:
- Publication type:
- Article
Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420935676
- By:
- Publication type:
- Article
Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420929467
- By:
- Publication type:
- Article
Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS).
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420922685
- By:
- Publication type:
- Article
Neurological manifestations and implications of COVID-19 pandemic.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420932036
- By:
- Publication type:
- Article
Stereo-crossed ablation guided by stereoelectroencephalography for epilepsy: comprehensive coagulations via a network of multi-electrodes.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420928657
- By:
- Publication type:
- Article
Low-dose statin pretreatment improves function and prognosis of recurrent ischemic stroke patients.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420920078
- By:
- Publication type:
- Article
Autoimmune glial fibrillary acidic protein astrocytopathy with lesions distributed predominantly in the entire spinal cord.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420909973
- By:
- Publication type:
- Article
The role of erenumab in the treatment of migraine.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420927119
- By:
- Publication type:
- Article
A critical appraisal of bypass surgery in moyamoya disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420921092
- By:
- Publication type:
- Article
Long-term outcomes of monascin – a novel dual peroxisome proliferator-activated receptor γ/nuclear factor-erythroid 2 related factor-2 agonist in experimental intracerebral hemorrhage.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420921083
- By:
- Publication type:
- Article
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420915005
- By:
- Publication type:
- Article
Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420911784
- By:
- Publication type:
- Article
Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420918088
- By:
- Publication type:
- Article
Higher sensitivity for traumatic cerebral microbleeds at 7 T ultra-high field MRI: is it clinically significant for the acute state of the patients and later quality of life?
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420911295
- By:
- Publication type:
- Article
Potential neurological symptoms of COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420904207
- By:
- Publication type:
- Article
Different risk factors in identical features of intracranial atherosclerosis plaques in the posterior and anterior circulation in high-resolution MRI.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420909991
- By:
- Publication type:
- Article
Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420910310
- By:
- Publication type:
- Article
PF-06649751 efficacy and safety in early Parkinson's disease: a randomized, placebo-controlled trial.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420911296
- By:
- Publication type:
- Article
Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286419898083
- By:
- Publication type:
- Article
Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286419887616
- By:
- Publication type:
- Article
Neurofilament light chain level in plasma extracellular vesicles and Parkinson’s disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420975917
- By:
- Publication type:
- Article
PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286419895155
- By:
- Publication type:
- Article
Short segment myelitis as the initial and only manifestation of aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286419898594
- By:
- Publication type:
- Article
Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420979954
- By:
- Publication type:
- Article
COVID-19 and cerebrovascular diseases: a comprehensive overview.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420978004
- By:
- Publication type:
- Article
Randomized controlled trial combining constraint-induced movement therapy and action-observation training in unilateral cerebral palsy: clinical effects and influencing factors of treatment response.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286419898065
- By:
- Publication type:
- Article
Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420975909
- By:
- Publication type:
- Article